rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-3-27
|
pubmed:abstractText |
Gene delivery to the myocardium using blood-borne adenoviral vectors is hindered by the endothelium, which represents a barrier limiting the infection rate of underlying myocytes. However, endothelial permeability may be modulated by pharmacological agents.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1099-498X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
42-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11269335-Adenoviridae,
pubmed-meshheading:11269335-Animals,
pubmed-meshheading:11269335-Capillary Permeability,
pubmed-meshheading:11269335-Cells, Cultured,
pubmed-meshheading:11269335-Endothelium, Vascular,
pubmed-meshheading:11269335-Gene Transfer Techniques,
pubmed-meshheading:11269335-Genetic Vectors,
pubmed-meshheading:11269335-Humans,
pubmed-meshheading:11269335-Male,
pubmed-meshheading:11269335-Muscle, Smooth,
pubmed-meshheading:11269335-Rats,
pubmed-meshheading:11269335-Rats, Wistar,
pubmed-meshheading:11269335-Thrombin
|
pubmed:articleTitle |
Increasing endothelial cell permeability improves the efficiency of myocyte adenoviral vector infection.
|
pubmed:affiliation |
INSERM U460, Faculté de Médecine Xavier Bichat, Paris, France. nevo@bichat.inserm.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|